Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy

Pediatric Transplantation

Volumn 10, Issue 5, 2006, Pages 565-569

  Falger, Jutta C ^a   Mueller, Thomas ^a,b   Arbeiter, Klaus ^a   Boehm, Michael ^a   Regele, Heinz ^a   Balzar, Egon ^a   Aufricht, Christoph ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

CAN; Children; Renal transplantation; Sirolimus

Indexed keywords

CALCINEURIN INHIBITOR; RAPAMYCIN;

ACNE; ADOLESCENT; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CHOLESTEROL BLOOD LEVEL; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; DIARRHEA; DRUG EFFECT; FEMALE; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INFECTIOUS COMPLICATION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; PEDIATRICS; RISK BENEFIT ANALYSIS; SIDE EFFECT;

ADOLESCENT; CALCINEURIN; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; SIROLIMUS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33745713210     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00515.x     Document Type: Article

References (26)

1. NANKIVELL BJ, BORROWS RJ, FUNG CL, O'CONNELL PJ, ALLEN RD, CHAPMAN JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003: 349: 2326-2333.
2. SOLEZ K, VINCENTI F, FILO RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group. Transplantation 1998: 66: 1736-1740.
3. TEJANI A, HO PL, EMMETT L, STABLEIN DM; North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Reduction in acute rejections decreases chronic rejection graft failure in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Transplant 2002: 2: 142-147.
4. KAHAN BD. The potential role of rapamycin in pediatric transplantation as observed from adult studies. Pediatr Transplant 1999: 3: 175-180.
5. ETTENGER RB, GRIMM EM. Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients. Am J Kidney Dis 2001: 38: S22-S28.
6. GUPTA P, KAUFMAN S, FISHBEIN TM. Sirolimus for solid organ transplantation in children. Pediatr Transplant 2005: 9: 269-276.
7. MULAY AV, HUSSAIN N, FERGUSSON D, KNOLL GA. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials. Am J Transplant 2005: 5: 1748-1756.
8. DOMINGUEZ J, MAHALATI K, KIBERD B, MCALISTER VC, MACDONALD AS. Conversion to rapamycin immunosuppression in renal transplant recipients: Report of an initial experience. Transplantation 2000: 70: 1244-1247.
9. EGIDI MF, COWAN PA, NASEER A, GABER AO. Conversion to sirolimus in solid organ transplantation: A single-center experience. Transplant Proc 2003: 35: 131S-137S.
10. CITTERLO F, SCATA MC, VIOLI P, et al. Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients. Transplant Proc 2003: 35: 1292-1294.
11. DIEKMANN F, BUDDE K, OPPENHEIMER F, FRITSCHE L, NEUMAYER HH, CAMPISTOL JM. Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction. Am J Transplant 2004: 4: 1869-1875.
12. WU MJ, SHU KH, CHENG CH, CHEN CH. Sirolimus in chronic allograft nephropathy. Transplant Proc 2004: 36: 2053-2055.
13. WU MS, CHANG CT, HUNG CC. Rapamycin in patients with chronic renal allograft dysfunction. Clin Transplant 2005: 19: 236-242.
14. WEBER T, ABENDROTH D, SCHELZIG H. Rapamycin rescue therapy in patients after kidney transplantation: First clinical experience. Transplant Int 2005: 18: 151-156.
15. WATSON CJ, FIRTH J, WILLIAMS PF, et al. A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation. Am J Transplant 2005: 5: 2496-2503.
16. BUMBEA V, KAMAR N, RIBES D, et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 2005: 20: 2517-2523.
17. SINDHI R, SEWARD J, MAZARIEGOS G, et al. Replacing calcineurin inhibitors with mTOR inhibitors in children. Pediatr Transplant 2005: 9: 391-397.
18. VILALTA R, VILA A, NIETO J, CALLIS L. Rapamycin use and rapid withdrawal of calcineurin inhibitors in pediatric renal transplantation. Transplant Proc 2003: 35: 703-704.
19. IBANEZ JP, MONTEVERDE ML, GOLDBERG J, DIAZ MA, TURCONI A. Sirolimus in pediatric renal transplantation. Transplant Proc 2005: 37: 682-684.
20. VESTER U, KRANZ B, NADALIN S, PAUL A, BECKER J, HOYER PF. Sirolimus rescue of renal failure in children after combined liver-kidney transplantation. Pediatr Nephrol 2005: 20: 686-689.
21. BUTANI L. Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue. Transplantation 2004: 78: 1362-1366.
22. DUDLEY C, POHANKA E, RIAD H, et al. Mycophenolate Mofetil Creeping Creatinine Study Group. Mycophenolate mofetil substitution for cyclosporine A in renal transplant recipients with chronic progressive allograft dysfunction: The 'creeping creatinine' study. Transplantation 2005: 79: 466-475.
23. RACUSEN LC, SOLEZ K, COLVIN RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713-723.
24. DHARNIDHARKA VR. Sirolimus in pediatric solid organ transplantation. Pediatr Transplant 2005: 9: 427-429.
25. ARBEITER K, PICHLER A, STEMBERGER R, et al. ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol 2004: 19: 222-226.
26. SCHACHTER AD, MEYERS KE, SPANEAS LD, et al. Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol. Pediatr Transplant 2004: 8: 171-177.